Lexaria Bioscience Corp (LEXX)
2.08
-0.08
(-3.70%)
USD |
NASDAQ |
Nov 22, 13:01
Lexaria Bioscience Enterprise Value: 25.27M for Nov. 21, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 21, 2024 | 25.27M |
| November 20, 2024 | 25.90M |
| November 19, 2024 | 25.43M |
| November 18, 2024 | 24.16M |
| November 15, 2024 | 22.90M |
| November 14, 2024 | 24.64M |
| November 13, 2024 | 26.85M |
| November 12, 2024 | 27.48M |
| November 11, 2024 | 27.64M |
| November 08, 2024 | 28.43M |
| November 07, 2024 | 27.80M |
| November 06, 2024 | 25.74M |
| November 05, 2024 | 26.38M |
| November 04, 2024 | 27.17M |
| November 01, 2024 | 27.80M |
| October 31, 2024 | 25.11M |
| October 30, 2024 | 27.01M |
| October 29, 2024 | 28.43M |
| October 28, 2024 | 30.96M |
| October 25, 2024 | 33.02M |
| October 24, 2024 | 34.28M |
| October 23, 2024 | 33.81M |
| October 22, 2024 | 34.76M |
| October 21, 2024 | 34.60M |
| October 18, 2024 | 34.76M |
| Date | Value |
|---|---|
| October 17, 2024 | 35.86M |
| October 16, 2024 | 36.49M |
| October 15, 2024 | 36.49M |
| October 14, 2024 | 39.50M |
| October 11, 2024 | 40.13M |
| October 10, 2024 | 39.50M |
| October 09, 2024 | 38.15M |
| October 08, 2024 | 39.50M |
| October 07, 2024 | 39.97M |
| October 04, 2024 | 41.55M |
| October 03, 2024 | 43.45M |
| October 02, 2024 | 43.29M |
| October 01, 2024 | 41.08M |
| September 30, 2024 | 39.34M |
| September 27, 2024 | 38.87M |
| September 26, 2024 | 38.08M |
| September 25, 2024 | 40.45M |
| September 24, 2024 | 40.45M |
| September 23, 2024 | 41.08M |
| September 20, 2024 | 42.66M |
| September 19, 2024 | 40.92M |
| September 18, 2024 | 42.03M |
| September 17, 2024 | 42.66M |
| September 16, 2024 | 44.40M |
| September 13, 2024 | 45.35M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
0.7568M
Minimum
May 10 2023
72.26M
Maximum
Mar 11 2024
20.23M
Average
19.42M
Median
Mar 09 2021
Enterprise Value Benchmarks
| Aurinia Pharmaceuticals Inc | 906.94M |
| Edesa Biotech Inc | 4.811M |
| Xenon Pharmaceuticals Inc | 2.380B |
| ESSA Pharma Inc | -52.60M |
| ImmunoPrecise Antibodies Ltd | 8.777M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -1.782M |
| Revenue (Quarterly) | 0.084M |
| Total Expenses (Quarterly) | 1.827M |
| EPS Diluted (Quarterly) | -0.13 |
| Profit Margin (Quarterly) | -2.12K% |
| Earnings Yield | -21.15% |
| Normalized Earnings Yield | -19.94 |